Intravitreal implant
Long-term follow-up of anatomical and functional macular changes after a single intravitreal implant of dexamethasone 0.7 mg for radiation macular edema secondary to proton beam therapy for choroidal melanoma
... single intravitreal implant of ...single intravitreal implant of dexamethasone could effectively and stably improve visual acuity and central retinal thickness in some patients with radiation ...
7
Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
... release intravitreal implant has been FDA approved for both the treatment of macular edema due to retinal vein occlusions and also for the treatment of noninfectious, posterior ...different ...
9
<p>Fluocinolone acetonide 0.19 mg intravitreal implant improves foveal thickness and reduces treatment burden for up to 1 year in eyes with persistent diabetic macular edema</p>
... This was a retrospective study of patients at one private practice in the US (Retina Associates of Cleveland, Cleveland, OH). The review was performed using informa- tion from electronic medical records collected between ...
9
Long-lasting corneal endothelial graft rejection successfully reversed after dexamethasone intravitreal implant
... Dexamethasone intravitreal implant has the advantage to reach prolonged intraocular therapeutic concentration with only one injection and with no need of surgical ...
5
Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
... of intravitreal corticosteroids is an important strategy in the treatment of non-infectious ...or intravitreal injection, or surgical implantation) have shown remarkable results in a number of past stud- ...
9
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
... and intravitreal (via pars plana) injection. To offset the short intravitreal half-life of corticosteroid solutions (~3 hours) and the need for frequent intravitreal injections, sustained-release ...
15
Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant
... FA intravitreal implant provides excellent control of uveitis in the majority of eyes with NIPU for up to ...FA implant that eventually underwent cataract surgery demonstrated better postoperative VA ...
7
<p>Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE</p>
... (FAc) intravitreal implant is approved in the United Arab Emirates (UAE) for treating diabetic macular edema (DME) in patients pre- viously treated with a course of corticosteroids and that did not have a ...
8
Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
... the intravitreal therapy, all patients underwent ophthalmic examination, which embraced: 1) BCVA using the Snellen visual acuity chart under identical testing con- ditions; 2) slit lamp examination including ...
7
A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
... In addition to having different efficacies for treating DME, DEX implants and anti-VEGF injection are associ- ated with varying degrees of increased risk of systemic and/or local complications over the period of ...
11
Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant
... and 80% of the naïve and 69.4% of the refractory patients required one or two additional DEX implants, with additional laser photocoagulation sessions. Both groups showed better BCVAs from the baseline in the follow-up ...
12
Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
... and implant misplacement and dislocation. Implant misplace- ment refers to injection of the implant into a tissue other than the vitreous, and implant dislocation refers to implant ...
16
Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
... This study is a retrospective, consecutive case series. In cluded patients were diagnosed with bilateral DME and had previously undergone consistent monthly bilateral intravitreal injections with an anti-VEGF ...
6
Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study
... had received previous treatment with anti-VEGF agents. Also, patients with prior pars plana vitrectomy, a surgical option for DME in some patients, were excluded. How- ever, it has been reported that DEX implant ...
9
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients
... of intravitreal injections on corneal ...after intravitreal ranibizumab and bevacizumab injections ...dexamethasone implant on corneal ...of intravitreal dexametasone implant on corneal ...
5
Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients
... Main outcome measures: The primary efficacy measurement was the percentage of patients who gained improvements of more than ten letters in best corrected visual acuity (BCVA) dur- ing 6 months of follow-up. Other ...
9
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
... of intravitreal anti-VEGF therapy, although the frequencies of these events have not proven to be sig- nificantly different from those seen in controls, in large ...
10
A 6-month, subject-masked, randomized controlled study to assess efficacy of dexamethasone as an adjunct to bevacizumab compared with bevacizumab alone in the treatment of patients with macular edema due to central or branch retinal vein occlusion
... if intravitreal bevacizumab combined with the dexamethasone intravitreal implant ...received intravitreal bevacizumab at baseline, followed by dexamethasone implants or sham injections 1 week ...
8
<p>Retinal angiographic alteration in diabetic macular edema after dexamethasone implantation: a case report</p>
... Dexamethasone intravitreal implant (DEX, brand name: Ozurdex) is a biode- gradable steroid delivery system that has been widely applied to patients with DME with favorable morphological and functional ...
7
Preliminary results of an intravitreal dexamethasone implant (Ozurdex<sup>®</sup>) in patients with persistent diabetic macular edema
... slow-release intravitreal dexamethasone implant, Ozurdex, shows efficacy for the treatment of DME, as both substantial improvements were registered in BCVA values, and signifi- cant reductions of CMT ...the ...
6